Cargando…
Improvement of peripheral artery disease with Sildenafil and Bosentan combined therapy in a patient with limited cutaneous systemic sclerosis: A case report
RATIONALE: Sildenafil, a phosphodiesterase-5-inhibitor and Bosentan, an endothelin-1-receptor antagonist combined therapy could have beneficial effect in systemic sclerosis (SSc) patients with peripheral artery disease. PATIENT CONCERNS: We report a case of a 48-year-old Black woman, who developed s...
Autores principales: | Omarjee, Loukman, Fontaine, Cedric, Mahe, Guillaume, Jaquinandi, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484185/ https://www.ncbi.nlm.nih.gov/pubmed/28640077 http://dx.doi.org/10.1097/MD.0000000000006988 |
Ejemplares similares
-
The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
por: Omarjee, Loukman, et al.
Publicado: (2017) -
Performance of noninvasive laser Doppler flowmetry and laser speckle contrast imaging methods in diagnosis of Buerger disease: A case report
por: Omarjee, Loukman, et al.
Publicado: (2018) -
Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature
por: Narváez, Javier, et al.
Publicado: (2016) -
Lower Doses of Bosentan in Combination With Sildenafil Might be Beneficial in Pulmonary Arterial Hypertension
por: Amin, Ahmad, et al.
Publicado: (2015) -
Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
por: Stivalet, Olivier, et al.
Publicado: (2021)